# Comparison of BioCart™II With Microfracture for Treatment of Cartilage Defects of the Femoral Condyle

> **NCT00729716** · PHASE2 · UNKNOWN · sponsor: **ProChon Biotech Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Symptomatic Cartilage Defects of the Femoral Condyle

## Interventions

- **BIOLOGICAL:** BioCart™II
- **PROCEDURE:** Microfracture

## Key facts

- **NCT ID:** NCT00729716
- **Lead sponsor:** ProChon Biotech Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2012-05
- **Final completion:** 2015-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2012-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00729716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00729716, "Comparison of BioCart™II With Microfracture for Treatment of Cartilage Defects of the Femoral Condyle". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00729716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*